September 25, 2009 - According to the Swissmedic agency, that agency along with an investigative judge are probing the death of a woman due to pulmonary embolism. The woman died suddenly within ten months of starting Yaz birth control pills. Bayer will conduct its own investigation according to a Bayer spokesman. Swissmedic is expected to release the results of its analysis in late-October of this year.
The investigation by Swissmedic is the latest in a series of health concerns raised over Yaz, Yasmin and the generic, Ocella. As previously reported in this blog, Bayer has come under fire from the FDA over its advertising practices and its manufacturing practices.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment